Invatec Overview

  • Founded
  • 1996
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 900
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Invatec General Information

Description

Provider of vascular interventional products for the treatment of cardiovascular disease. The company offers endovascular treatment of critical limb ischemia, carotid artery stenting and provides drug eluting balloon, treating arteries in the coronary and the upper/lower leg for the purpose of maximizing the long term patency of diseased vessels.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Medical Supplies
Other Industries
Surgical Devices
Other Devices and Supplies
Acquirer
Golden Max
Primary Office
  • Via Martiri della Libertà 7
  • 25030 Roncadelle
  • Italy
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Invatec Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Invatec‘s full profile, request access.

Request a free trial

Invatec Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Invatec Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Invatec‘s full profile, request access.

Request a free trial